参考文献/References:
[1]王君霞,关婷.宫颈癌中骨桥蛋白的表达及与新辅助化疗敏感性关系的研究[J].发育医学电子杂志,2013,1(1):16-22.
[2]陈万青,张思维,曾红梅,等.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10.
[3]刘月仙.妇科门诊育龄妇女HPV感染与宫颈癌筛查情况分析[J].实用癌症杂志,2014,27(2):132-134.
[4]Wan Lei,Wan Jianping,Zhang Yanling,et al.Clinical Analysis of the Trend of Carcinoma of the Cervix in Young Women[J].Chinese Journal of Clinical Oncology,2014,31(10):547.
[5]黄雯,朱瑾.吸烟与宫颈癌[J].中华妇产科杂志,2012,47(5):391-393.
[6]钱德英.阴道镜在宫颈癌诊断中的应用[J].中国实用妇科与产科杂志,2003,19(3):137-139..
[7]赵方辉,章文华,潘秦镜,等.宫颈癌多种筛查方案的研究[J].中华肿瘤杂志,2013,32(6):420-424.
[8]刘晓明.200例妇女宫颈癌筛查及预防的研究[J].现代中西医结合杂志,2012,21(2):169-170.
[9]韦红卫,黄卫彤,罗小琼.醋酸肉眼检查法在宫颈癌筛查中的应用研究[J].临床医学,2015,18(9):1166.
[10]何龙明,杨玉芩,谭彩菊,等.巴氏涂片技术在贫困山区农村妇女宫颈癌筛查中的意义[J].中国妇幼保健,2010,25(26):3698-3699.
[11]赵同香,邓小虹,韩历丽.宫颈癌筛查状况及评价指标研究进展[J].中华疾病控制杂志,2013,17(8):715-717.
[12]陈娇,孔为民.宫颈癌筛查方法的现状与研究进展[J].医学综述,2016,22(12):2338-2342.
[13]侯安存,杨爱君.人乳头瘤病毒疫苗预防宫颈癌的研究进展[J].临床和实验医学杂志,2017,16(4):414-417.
[14]赵轩胤.不同程度宫颈病变患者血清中鳞状上皮细胞癌抗原水平[J].贵州医科大学学报,2017,42(2):202-204,208.
[15]侯煜,杨天敬.宫颈癌筛查方法的研究进展[J].哈尔滨医药,2007,27(5):49-50.
[16]刘霏.宫颈癌的手术治疗[J].抗癌,2015,28(4):17-18.
[17]周青.宫颈癌化疗患者护理干预对生存质量的影响[J].解放军医院管理杂志,2017,24(3):285-287,291.
[18]张雅丽,赵敏,银亮.内蒙古蒙古族和汉族女性宫颈HPV感染情况比较研究[J].疾病监测与控制,2017,11(1):54-56.
[19]曾琴.酚红对无血清悬浮培养条件下肿瘤干细胞微球形成的影响[J].华西药学杂志,2017,32(4):388-390.
[20]毛金珠.舒适护理干预模式在宫颈癌患者中的应用价值分析[J].基层医学论坛,2017,21(12):1565-1566.
相似文献/References:
[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Journal of Medical Information,2018,31(09):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]蔡亚磊,邓思雨,杨 健.宫颈癌放疗增敏的研究现状[J].医学信息,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
CAI Ya-lei,DENG Si-yu,YANG Jian.Research Status of Radiotherapy Sensitization for Cervical Cancer[J].Journal of Medical Information,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
[3]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Journal of Medical Information,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
[4]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Journal of Medical Information,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[5]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(09):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[6]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Journal of Medical Information,2018,31(09):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[7]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Journal of Medical Information,2018,31(09):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[8]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Journal of Medical Information,2018,31(09):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[9]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Journal of Medical Information,2018,31(09):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[10]吴晓玲,周桂华.miR-187在宫颈癌中的表达与临床病理关系的研究[J].医学信息,2018,31(16):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
WU Xiao-ling,ZHOU Gui-hua.Expression of miR-187 in Cervical Cancer and Its Relationship with Clinicopathological Features[J].Journal of Medical Information,2018,31(09):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
[11]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者
分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Journal of Medical Information,2018,31(09):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]